Conference icon

Conference

Incidence of hemolytic anemia after chemotherapy in the CLL4 trial. A possible protective role for fludarabine plus cyclophosphamide.

Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Trial Service Unit
Role:
Author
Volume:
104
Issue:
11
Pages:
140A-140A
Publication date:
2004-11-16
ISSN:
0006-4971
URN:
uuid:bdf1a842-1cc6-439d-8342-b797126db246
Source identifiers:
95966
Local pid:
pubs:95966

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP